Jeisys Medical Inc
KOSDAQ:287410
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Jeisys Medical Inc
Accounts Receivables
Jeisys Medical Inc
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
J
|
Jeisys Medical Inc
KOSDAQ:287410
|
Accounts Receivables
₩14B
|
CAGR 3-Years
40%
|
CAGR 5-Years
270%
|
CAGR 10-Years
N/A
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Accounts Receivables
₩67.8B
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Accounts Receivables
₩48.9B
|
CAGR 3-Years
89%
|
CAGR 5-Years
74%
|
CAGR 10-Years
94%
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Accounts Receivables
₩19.4B
|
CAGR 3-Years
1 378%
|
CAGR 5-Years
478%
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Accounts Receivables
₩7.5B
|
CAGR 3-Years
40%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Accounts Receivables
₩4.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Jeisys Medical Inc
Glance View
Jeisys Medical, Inc. manufactures and develops products used by plastic surgeons, dermatologist, physicians and health professionals. The company is headquartered in Seoul, Seoul. The company went IPO on 2018-05-08. The firm manufactures and sells skin care medical devices such as ULTRAcel Q+, POTENZA, and other products. In addition, the Company also provides consumables such as cartridges and tips.
See Also
What is Jeisys Medical Inc's Accounts Receivables?
Accounts Receivables
14B
KRW
Based on the financial report for Jun 30, 2024, Jeisys Medical Inc's Accounts Receivables amounts to 14B KRW.
What is Jeisys Medical Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
270%
Over the last year, the Accounts Receivables growth was 84%. The average annual Accounts Receivables growth rates for Jeisys Medical Inc have been 40% over the past three years , 270% over the past five years .
